AAAAAA
Results:
1-16
|
Results: 16
Authors:
Meschler, JP
Howlett, AC
Madras, BK
Citation: Jp. Meschler et al., Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates, PSYCHOPHAR, 156(1), 2001, pp. 79-85
Authors:
Meschler, JP
Howlett, AC
Citation: Jp. Meschler et Ac. Howlett, Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum, NEUROPHARM, 40(7), 2001, pp. 918-926
Authors:
Hudson, TY
Corbett, JA
Howlett, AC
Klein, C
Citation: Ty. Hudson et al., Nitric oxide regulates adenylyl cyclase activity in rat striatal membranes, J NEUROCHEM, 77(5), 2001, pp. 1279-1284
Authors:
Mukhopadhyay, S
Howlett, AC
Citation: S. Mukhopadhyay et Ac. Howlett, CB1 receptor-C protein association - Subtype selectivity is determined by distinct intracellular domains, EUR J BIOCH, 268(3), 2001, pp. 499-505
Authors:
Meschler, JP
Conley, TJ
Howlett, AC
Citation: Jp. Meschler et al., Cannabinoid and dopamine interaction in rodent brain: effects on locomotoractivity, PHARM BIO B, 67(3), 2000, pp. 567-573
Authors:
Mukhopadhyay, S
McIntosh, HH
Houston, DB
Howlett, AC
Citation: S. Mukhopadhyay et al., The CB1 cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain, MOLEC PHARM, 57(1), 2000, pp. 162-170
Authors:
Meschler, JP
Clarkson, FA
Mathews, PJ
Howlett, AC
Madras, BK
Citation: Jp. Meschler et al., D-2, but not D-1 dopamine receptor agonists potentiate cannabinoid-inducedsedation in nonhuman primates, J PHARM EXP, 292(3), 2000, pp. 952-959
Authors:
Howlett, AC
Wilken, GH
Pigg, JJ
Houston, DB
Lan, RX
Liu, Q
Makriyannis, A
Citation: Ac. Howlett et al., Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction, J NEUROCHEM, 74(5), 2000, pp. 2174-2181
Authors:
Howlett, AC
Mukhopadhyay, S
Citation: Ac. Howlett et S. Mukhopadhyay, Cellular signal transduction by anandamide and 2-arachidonoylglycerol, CHEM PHYS L, 108(1-2), 2000, pp. 53-70
Authors:
Meschler, JP
Kraichely, DM
Wilken, GH
Howlett, AC
Citation: Jp. Meschler et al., Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxypheny-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor, BIOCH PHARM, 60(9), 2000, pp. 1315-1323
Authors:
Berglund, BA
Boring, DL
Wilken, GH
Makriyannis, A
Howlett, AC
Lin, S
Citation: Ba. Berglund et al., Structural requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid receptors: pharmacology of the carbonyl and ethanolamidegroups (vol 59, pg 111, 1998), PROS LEUK E, 60(2), 1999, pp. 140-140
Authors:
Howlett, AC
Citation: Ac. Howlett, Reefer medics, ISSUES SCI, 16(1), 1999, pp. 17-18
Authors:
Meschler, JP
Howlett, AC
Citation: Jp. Meschler et Ac. Howlett, Thujone exhibits low affinity for cannabinoid receptors but fails to evokecannabimimetic responses, PHARM BIO B, 62(3), 1999, pp. 473-480
Authors:
Howlett, AC
Mukhopadhyay, S
Shim, JY
Welsh, WJ
Citation: Ac. Howlett et al., Signal transduction of eicosanoid CB1 receptor ligands, LIFE SCI, 65(6-7), 1999, pp. 617-625
Authors:
Mukhopadhyay, S
Cowsik, SM
Lynn, AM
Welsh, WJ
Howlett, AC
Citation: S. Mukhopadhyay et al., Regulation of G(i) by the CB1 cannabinoid receptor c-terminal juxtamembrane region: Structural requirements determined by peptide analysis, BIOCHEM, 38(11), 1999, pp. 3447-3455
Authors:
Howlett, AC
Citation: Ac. Howlett, The CB1 cannabinoid receptor in the brain, NEUROBIOL D, 5(6), 1998, pp. 405-416
Risultati:
1-16
|